| Name | The Pharmacy |
|---|---|
| Organization Name | Osie Inc. |
| Location | 1221 N Cotner Blvd, Ste 1, Lincoln, Nebraska 68505 |
| Type | Community/Retail Pharmacy |
| Phone | (402) 466-6082 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A revolutionary surgery developed by Dr. Richard Hopper, surgical director of Seattle Children's Craniofacial Center, called subcranial rotation distraction, is changing the lives of children who are tracheostomy dependent.
To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.
Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death. This is according to a new study by Hannah Gardener and her colleagues from the University of Miami Miller School of Medicine and at Columbia University Medical Center.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
› Verified 5 days ago
| NPI Number | 1558328997 |
| Organization Name | OSIE INC. |
| Doing Business As | THE PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 1221 N Cotner Blvd, Suite 1, Lincoln, NE 68505 |
| Phone Number | 402-466-7283 |
News Archive
A revolutionary surgery developed by Dr. Richard Hopper, surgical director of Seattle Children's Craniofacial Center, called subcranial rotation distraction, is changing the lives of children who are tracheostomy dependent.
To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.
Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death. This is according to a new study by Hannah Gardener and her colleagues from the University of Miami Miller School of Medicine and at Columbia University Medical Center.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
› Verified 5 days ago
News Archive
A revolutionary surgery developed by Dr. Richard Hopper, surgical director of Seattle Children's Craniofacial Center, called subcranial rotation distraction, is changing the lives of children who are tracheostomy dependent.
To the surprise of researchers at Mayo Clinic who led a national clinical trial, a targeted therapy that provides benefit to patients with metastatic colon cancer has failed to help patients with less advanced, stage III cancer. In fact, patients who used the agent, cetuximab, with chemotherapy had outcomes slightly inferior to patients treated with chemotherapy alone.
Individuals who drink diet soft drinks on a daily basis may be at increased risk of suffering vascular events such as stroke, heart attack, and vascular death. This is according to a new study by Hannah Gardener and her colleagues from the University of Miami Miller School of Medicine and at Columbia University Medical Center.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the presentation of interim results from the ongoing Phase 1 trial evaluating CAL-101, an oral delta-selective PI3K inhibitor, demonstrating promising clinical responses in patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
› Verified 5 days ago
Able Ii Prosthetics And Orthotics Type: Medicare Supplier Location: 2222 S 16th St, Lincoln, Nebraska 68502 Phone: (402) 483-8898 | |
Acs Medical Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 233 N 48th St, Lincoln, Nebraska 68504 Phone: (402) 467-1014 | |
Ahp-mhr Homecare Llp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1801 Cushman Dr, Lincoln, Nebraska 68512 Phone: (402) 420-7744 | |
Russ's Pharmacy #1 Type: Community/Retail Pharmacy Location: 1709 Washington St, Lincoln, Nebraska 68502 Phone: (402) 474-2102 | |
Russ's Pharmacy #21 Type: Community/Retail Pharmacy Location: 1550 S Coddington Ave, Lincoln, Nebraska 68522 Phone: (402) 435-8241 |